News

Euroscreen completes enrolment in Phase II trial of lead candidate ESN364 in Menopausal Hot Flashes

on 14/09/2016 10:48
Study evaluating ESN364, a novel, non-hormonal small-molecule drug designed to block Hot Flashes avoiding Hormone Replacement Therapy (HRT), known to increase the incidence of cancer in menopausal women.
Read more

Mainstay Medical’s ReActiv8-B Clinical Trial for treatment of Chronic Low Back Pain enrols First Subject

on 14/09/2016 10:35
Trial to gather data in support of an application for US pre-market approval (PMA)
Read more

Green Biologics and Acme Hardesty launch bio-based esters for personal care markets

on 07/09/2016 15:12
Full Range of 100 percent bio-based esters introduced at in-cosmetics show in NYC
Read more

FDA clears icometrix’ image quantification software to monitor neurological disorders such as Multiple Sclerosis

on 07/09/2016 11:10
icometrix is the global market leader in brain MRI biomarkers for clinical neuroimaging.
Read more

Confo Therapeutics appoints Dr Cedric Ververken as Chief Executive Officer

on 07/09/2016 10:50